BLSH vs CRCL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

BLSH

37.4
AI Score
VS
BLSH Wins

CRCL

51.0
AI Score

Investment Advisor Scores

BLSH

37score
Recommendation
AVOID NEW MONEY

CRCL

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BLSH CRCL Winner
Forward P/E 58.8235 74.6269 BLSH
PEG Ratio 0 6.8553 Tie
Revenue Growth 68.8% 6.6% BLSH
Earnings Growth 0.0% -80.9% BLSH
Tradestie Score 37.4/100 51.0/100 CRCL
Profit Margin 0.0% 15.5% CRCL
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CRCL

Relative Price Performance (Last 90 Days)

BLSH 1M: +4.9% · 3M: +28.8% CRCL 1M: -8.3% · 3M: +18.4%

Current Technical Phase

BLSH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.5 · Price: $34.23

CRCL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 43.9 · Price: $81.25

Fundamentals Snapshot

Metric BLSH CRCL
Market Cap — —
Forward P/E 10.5 58.5
Trailing P/E — 16.5
Revenue (TTM) — —
Revenue Growth 0.7% 0.1%
Gross Margin 1.0% 0.2%
Operating Margin -3.1% 0.0%
EPS -10.00 5.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BLSH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.